Thursday, July 23, 2026
ESMO Gastrointestinal Cancers Congress pharmaceutical event banner
← Back to Events
Tier 1 Global Networking: High ONCOLOGY CONCLUDED

ESMO Gastrointestinal Cancers Congress — 2026 — Munich, Germany

The ESMO Gastrointestinal Cancers Congress 2026 will take place from 1 to 4 July in Munich, Germany, as well as online, through a dedicated virtual platform. Answer who/what/when/where for ESMO Gastrointestinal Cancers Congress 2027 with verified dates, location, and what B2B rea

Munich, Germany July 1 – July 4, 2026
1 Presentations
1 Companies
1 Drugs
All Events

Presentation data updated Jul 22, 2026, 5:17 AM UTC

Nova Event Impact Score
32 /100
  • Media coverage 6/20
  • Speaker quality 14/20
  • Pipeline relevance 0/20
  • Historical influence 10/20
  • Company participation 2/20

Key Takeaways

Key Themes

oncologyESMOPipeline announcementsPartnership deals

Key Companies

Bristol-Myers Squibb

Key Drugs

nivolumab

Key Markets

Europe

Key Opportunities

Partnership dealsLicensing discussionsVendor selection
Best for
Oncology BD teams Clinical development leaders Investors & analysts

Full Schedule

1 presentations

POSTER

POSTER

Efficacy results from a MAIC suggest potential benefit with nivolumab/ipilimumab over other first-line IO-based regimens in first-line unresectable HCC

Bristol-Myers Squibb$BMY nivolumab(Opdivo, Yervoy) unresectable hepatocellular carcinoma (first-line)
INVESTOR IMPACT: ★☆☆☆☆ 1/5